BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8503561)

  • 1. Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung.
    Chanez P; Lacoste JY; Guillot B; Giron J; Barnéon G; Enander I; Godard P; Michel FB; Bousquet J
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1497-502. PubMed ID: 8503561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrosing alveolitis in systemic sclerosis. Bronchoalveolar lavage findings in relation to computed tomographic appearance.
    Wells AU; Hansell DM; Rubens MB; Cullinan P; Haslam PL; Black CM; Du Bois RM
    Am J Respir Crit Care Med; 1994 Aug; 150(2):462-8. PubMed ID: 8049830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fibrosing alveolitis of systemic sclerosis.
    Wells AU; Hansell DM; Haslam PL; Rubens MB; Cailes J; Black CM; du Bois RM
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1474-82. PubMed ID: 9603126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil activation in fibrosing alveolitis: a comparison of lone cryptogenic fibrosing alveolitis and systemic sclerosis.
    Cailes JB; O'Connor C; Pantelidis P; Southcott AM; Fitzgerald MX; Black CM; du Bois RM
    Eur Respir J; 1996 May; 9(5):992-9. PubMed ID: 8793462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cell tryptase and histamine concentrations in bronchoalveolar lavage fluid from patients with interstitial lung disease.
    Walls AF; Bennett AR; Godfrey RC; Holgate ST; Church MK
    Clin Sci (Lond); 1991 Aug; 81(2):183-8. PubMed ID: 1653661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis.
    Witt C; Borges AC; John M; Fietze I; Baumann G; Krause A
    Ann Rheum Dis; 1999 Oct; 58(10):635-40. PubMed ID: 10491363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Suberosis: involvement of bronchoalveolar +mastocytes in the genesis of interstitial involvement].
    Delgado L; Cuesta C; Winck JC; Sapage JM; Moura e Sá J; Fleming Torrinha JA
    Arch Bronconeumol; 1999 Feb; 35(2):71-8. PubMed ID: 10099726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis.
    De Santis M; Bosello S; La Torre G; Capuano A; Tolusso B; Pagliari G; Pistelli R; Danza FM; Zoli A; Ferraccioli G
    Respir Res; 2005 Aug; 6(1):96. PubMed ID: 16107215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity.
    Miller KS; Smith EA; Kinsella M; Schabel SI; Silver RM
    Am Rev Respir Dis; 1990 Feb; 141(2):301-6. PubMed ID: 2301848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchoalveolar lavage in systemic sclerosis with lung involvement: role and correlations with functional, radiological and scintigraphic parameters.
    Volpinari S; La Corte R; Bighi S; Ravenna F; Prandini N; Lo Monaco A; Trotta F
    Rheumatol Int; 2011 Sep; 31(9):1183-8. PubMed ID: 20352228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclophosphamide reduces neutrophilic alveolitis in patients with scleroderma lung disease: a retrospective analysis of serial bronchoalveolar lavage investigations.
    Kowal-Bielecka O; Kowal K; Rojewska J; Bodzenta-Lukaszyk A; Siergiejko Z; Sierakowska M; Sierakowski S
    Ann Rheum Dis; 2005 Sep; 64(9):1343-6. PubMed ID: 16100339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of high-resolution thoracic computerized tomography and bronchoalveolar lavage in 36 patients presenting with systemic disease and a normal thoracic radiography].
    Dansin E; Wallaert B; Rémy-Jardin M; Perez T; Hatron PY; Rémy J; Tonnel AB
    Rev Mal Respir; 1991; 8(6):551-8. PubMed ID: 1775714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance.
    Harrison NK; Glanville AR; Strickland B; Haslam PL; Corrin B; Addis BJ; Lawrence R; Millar AB; Black CM; Turner-Warwick M
    Respir Med; 1989 Sep; 83(5):403-14. PubMed ID: 2694236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis.
    Wells AU; Hansell DM; Rubens MB; Cullinan P; Black CM; du Bois RM
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1076-82. PubMed ID: 8214928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship Between Abnormalities on High-Resolution Computerized Tomography, Pulmonary Function, and Bronchoalveolar Lavage in Progressive Systemic Sclerosis.
    Cakmak G; Selcuk Can T; Gundogdu S; Akman C; Ikitimur H; Musellim B; Ongen G
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):349-354. PubMed ID: 28079847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage.
    Silver RM; Miller KS; Kinsella MB; Smith EA; Schabel SI
    Am J Med; 1990 May; 88(5):470-6. PubMed ID: 2337105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cell and histamine content of human bronchoalveolar lavage fluid.
    Agius RM; Godfrey RC; Holgate ST
    Thorax; 1985 Oct; 40(10):760-7. PubMed ID: 4060097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional impairment in lone cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a comparison.
    Wells AU; Hansell DM; Rubens MB; Cailes JB; Black CM; du Bois RM
    Am J Respir Crit Care Med; 1997 May; 155(5):1657-64. PubMed ID: 9154872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical pulmonary involvement assessed by bronchoalveolar lavage in patients with early undifferentiated connective tissue disease.
    Kumánovics G; Zibotics H; Juhász E; Komócsi A; Czirják L
    Clin Exp Rheumatol; 2001; 19(5):551-9. PubMed ID: 11579714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-8. Differential expression in lone fibrosing alveolitis and systemic sclerosis.
    Southcott AM; Jones KP; Li D; Majumdar S; Cambrey AD; Pantelidis P; Black CM; Laurent GJ; Davies BH; Jeffery PK
    Am J Respir Crit Care Med; 1995 May; 151(5):1604-12. PubMed ID: 7735620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.